Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Neurology
|
May 1, 1994
Latency and duration of the muscle silent period following transcranial magnetic stimulation in multiple sclerosis, cerebral ischemia, and other upper motoneuron lesions
B A Haug, B Kukowski
European Neurology
|
January 1, 1991
Orofacial and respiratory tardive dyskinesia: potential side effects of 2-dimethylaminoethanol (deanol)?
B A Haug, M Holzgraefe
Neuroreport
|
April 29, 1998
Selective activation of human cortical area V5A by a rotating visual stimulus in fMRI; implication of attentional mechanisms
B A Haug, J Baudewig, W Paulus
Der Nervenarzt
|
October 1, 1991
[Speech apraxia in dialysis-associated aluminum encephalopathy]
B A Haug, G Botsch, K Felgenhauer
Journal of Neurology
|
February 1, 1990
Polyradiculoneuritis following botulinum toxin therapy
B A Haug, D Dressler, H W Prange
Vision Research
|
January 13, 1998
Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment
B A Haug, E M Hermsteiner, B Bandelow, et al.
Electroencephalography and Clinical Neurophysiology
|
April 1, 1992
Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulation
B A Haug, P W Schönle, C Knobloch, et al.
Zentralblatt Fur Pathologie
|
July 1, 1994
Malignant gliomas--ploidy and DNA-content before and after therapy
M E Pilichowska, P Schröter, B A Haug, et al.
Clinical Neurology and Neurosurgery
|
January 1, 1989
Morvan's fibrillary chorea. A case with possible manganese poisoning
B A Haug, P W Schoenle, B J Karch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 1, 1994
Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease
B A Haug, C Trenkwalder, G B Arden, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Neurology
|
May 1, 1994
Latency and duration of the muscle silent period following transcranial magnetic stimulation in multiple sclerosis, cerebral ischemia, and other upper motoneuron lesions
B A Haug, B Kukowski
European Neurology
|
January 1, 1991
Orofacial and respiratory tardive dyskinesia: potential side effects of 2-dimethylaminoethanol (deanol)?
B A Haug, M Holzgraefe
Neuroreport
|
April 29, 1998
Selective activation of human cortical area V5A by a rotating visual stimulus in fMRI; implication of attentional mechanisms
B A Haug, J Baudewig, W Paulus
Der Nervenarzt
|
October 1, 1991
[Speech apraxia in dialysis-associated aluminum encephalopathy]
B A Haug, G Botsch, K Felgenhauer
Journal of Neurology
|
February 1, 1990
Polyradiculoneuritis following botulinum toxin therapy
B A Haug, D Dressler, H W Prange
Vision Research
|
January 13, 1998
Parallel increase of heterochromatic increment threshold and postadaptation thresholds in Parkinson's disease and in neuroleptic treatment
B A Haug, E M Hermsteiner, B Bandelow, et al.
Electroencephalography and Clinical Neurophysiology
|
April 1, 1992
Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulation
B A Haug, P W Schönle, C Knobloch, et al.
Zentralblatt Fur Pathologie
|
July 1, 1994
Malignant gliomas--ploidy and DNA-content before and after therapy
M E Pilichowska, P Schröter, B A Haug, et al.
Clinical Neurology and Neurosurgery
|
January 1, 1989
Morvan's fibrillary chorea. A case with possible manganese poisoning
B A Haug, P W Schoenle, B J Karch, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
September 1, 1994
Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson's disease
B A Haug, C Trenkwalder, G B Arden, et al.
Page
of 2